Overview
Molecular genetics of glomerular disease
Genetic risk factors for childhood onset idiopathic nephrotic syndrome
Genetic risk factors for childhood onset idiopathic nephrotic syndrome
Current Duke Appointments & Affiliations
Wilburt C. Davison Distinguished Professor
·
2021 - Present
Pediatrics, Nephrology,
Pediatrics
Professor of Pediatrics
·
2018 - Present
Pediatrics, Nephrology,
Pediatrics
Associate Dean for Physician-Scientist Development
·
2021 - Present
School of Medicine
Director of the Office of Physician-Science Development in the School of Medicine
·
2021 - Present
School of Medicine
Chief, Division of Pediatric Nephrology
·
2025 - Present
Pediatrics, Nephrology,
Pediatrics
Professor in Medicine
·
2018 - Present
Medicine, Nephrology,
Medicine
Affiliate of the Duke Molecular Physiology Institute
·
2014 - Present
Duke Molecular Physiology Institute,
Institutes and Centers
Recent Scholarly Works
Gene-disease relationships for glomerular phenotypes: expert recommendations from ClinGen.
Journal article Nat Rev Nephrol · August 2026 Glomerular diseases are complex conditions, many of which have a genetic basis. However, although some genetic variants can affect glomerular and thereby kidney function, not all identified variants are pathogenic. The process of evaluating genetic and exp ... Full text Link to item CiteElucidating Therapeutic Targets in Hereditary Multicentric Carpotarsal Osteolysis FSGS.
Journal article J Am Soc Nephrol · July 20, 2026 Full text Link to item CiteFood Insecurity and Blood Pressure in West Africans with Chronic Kidney Disease
Journal article Clinical Epidemiology and Global Health · July 1, 2026 Background/aims: Food insecurity, limited/uncertain access to adequate food, is a growing concern, especially in low- and middle-income countries, where it may exacerbate chronic kidney disease (CKD). Evidence on the relationship between food insecurity an ... Full text CiteRecent Grants
2/3 CTSA K12 Program at Duke University
ResearchPrincipal Investigator · Awarded by National Center for Advancing Translational Sciences · 2025 - 2030APOL1 - associated nephropathy from human-derived, intrarenal perspective
ResearchPrincipal Investigator · Awarded by Boston Children's Hospital · 2025 - 2030Phase 2b Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Dose-Ranging Study to Assess the Efficacy, Safety, and Tolerability of AZD2373 in Participants with APOL1-Mediated Ki
Clinical TrialPrincipal Investigator · Awarded by AstraZeneca AB · 2025 - 2029View All Grants
Education
University of Ibadan, College of Medicine (Nigeria) ·
1987
M.B.B.S.